India's Pharmaceutical Exports

Country Profile

Saint Lucia

Saint Lucia is a developing market for Indian pharmaceuticals — $2.45M in FY 2025–26, with 4.5× growth over the past decade. Medicines accounts for 77% of shipments, with vaccines contributing $28K. The compound annual growth rate since FY2016 stands at 16.3%.

🇱🇨 $2.45M · 4.5× growth since FY2016 · 16.3% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$2.45M
Exports FY2025–26 DGCIS
4.5×
Growth FY2016→2026
16.3%
CAGR FY2016→2026
77%
Medicines Share
4
Product Categories Supplied
Saint Lucia is a developing market for Indian pharmaceuticals — $2.45M in FY 2025–26, with 4.5× growth over the past decade. Medicines accounts for 77% of shipments, with vaccines contributing $28K. The compound annual growth rate since FY2016 stands at 16.3%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $1.88M (77.0%) Surgical & Hospital Supplies $452K (18.5%) Traditional & Herbal $83K (3.4%) Vaccines $28K (1.1%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Saint Lucia in the RBI overseas direct investment dataset (2011–2026).